SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending following the company's inclusion in the Euro STOXX 50 index and increased optimism surrounding its role in AI infrastructure, bolstered by a significant investment from Google in Finland. While some traders view the recent price volatility as institutional manipulation, others remain bullish on the long-term potential of Nokia's AI-RAN technology and its strategic partnerships.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense community speculation surrounding an upcoming procedural Senate vote on the Clarity Act. While some traders expect the vote to serve as a bullish catalyst, others warn of a potential "buy the rumor, sell the news" event or legislative failure that could trigger a broader market downturn.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's is trending following a significant earnings miss and weak comparable sales, prompting widespread debate over the company's financial stability and turnaround strategy. While some traders express concerns about potential bankruptcy and declining consumer discretionary spending, others maintain a bullish outlook based on the company's cash flow improvements and potential for a short squeeze.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Shares are trending higher following reports that Anthropic has committed to a multi-year $13.7 billion compute deal with the company's neocloud unit. While some traders express optimism regarding the company's expansion into AI infrastructure, others highlight potential risks such as share dilution, the need for further capital to fund data center development, and broader market concerns regarding AI safety debates.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

The community is heavily focused on the upcoming release of maintenance trial data for VK2735, with traders debating whether management will time the announcement to coincide with investor conferences or if the stock is being suppressed by short-sellers awaiting the results. Sentiment remains polarized between long-term bullishness based on the drug's potential efficacy and frustration over the CEO's communication style and the lack of a near-term buyout announcement.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending following a significant sell-off triggered by the announcement of a $2 billion at-the-market equity offering. Traders are actively debating whether the decline represents an unjustified overreaction to shareholder dilution or a necessary correction amid broader concerns regarding AI infrastructure spending.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to significant investor optimism surrounding the company's strong earnings results and record backlog, which analysts suggest positions the firm well to benefit from surging power infrastructure demand for AI data centers. While some traders are expressing frustration over recurring equity offerings, others remain bullish on the long-term growth story and the stock's capacity to rebound.

The Elmet Group Co. engages in the provision of precision-engineered components. The firm offers its products and solutions to aerospace, defense, industrial, medical, semiconductor, electronics, energy industry and also the government. It operates through the Critical Materials Components and Engineered Microwave Products business divisions. The company was founded on September 13, 2024 and is headquartered in Portland, ME.

Elmet Group Co. (The)

The Elmet Group

The Elmet Group is surging following a multi-billion dollar agreement with the U.S. government, which includes a $450 million investment from the Department of War and a $2 billion defense contract to bolster domestic tungsten supply chains. While bulls highlight the company's strategic role in national security and potential for long-term growth, some traders are expressing caution regarding potential future dilution or viewing the rapid price appreciation as unsustainable.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is trending following remarks from CEO Brian Moynihan at the Barclays Global Financial Services Conference, where he indicated that third-quarter sales and trading revenue would be relatively flat compared to the previous year. Traders have reacted with significant volatility, evidenced by a sharp selloff that pushed the stock below its 50-day moving average, though some participants are debating whether the reaction constitutes a classic panic sell or a justified repricing.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

SOXS is trending as traders speculate on a potential sector-wide correction for semiconductors, driven by concerns over AI-related capital expenditure sustainability, debt levels, and broader macroeconomic headwinds like rising bond yields and inflation. Community sentiment remains polarized, with some investors leveraging the inverse ETF to bet on a reversal, while others warn of the structural decay associated with leveraged funds and maintain a bullish outlook on the chip sector long-term.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anavex Life Sciences (AVXL) to Release Earnings on Tuesday

Anavex Life Sciences (NASDAQ:AVXL) will be releasing its Q2 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-anavex-life-sciences-corp-stock...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts

Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) have received an average recommendation of 'Hold' from the five brokerages that are currently covering the firm, Marketbeat...

Anavex Life Sciences (NASDAQ:AVXL) Coverage Initiated by Analysts at Rodman & Renshaw

Rodman & Renshaw initiated coverage on shares of Anavex Life Sciences in a report on Monday. They set a 'buy' rating and a $20.00 target price on the stock...

Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200 Day Moving Average - Time to Sell?

Anavex Life Sciences (NASDAQ:AVXL) Stock Passes Below Two Hundred Day Moving Average - Here's Why...

Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200-Day Moving Average   - Time to Sell?

Anavex Life Sciences (NASDAQ:AVXL) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened...

Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference

Anavex Life Sciences (NASDAQ:AVXL) is prioritizing upcoming pivotal studies and continued regulatory engagement as it seeks potential pathways to market authorization for its oral central nervous...

Anavex Life Sciences' (AVXL) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital reissued a "buy" rating and issued a $24.00 price target on shares of Anavex Life Sciences in a research note on Tuesday...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback

Anavex shares fall after pulling EU filing for blarcamesine in Alzheimer's; EMA feedback prompts more data work.read more...

AVXL Stock Tanks After Anavex Withdraws EU Bid For Alzheimer's Drug

Equity

Anavex stated that the decision to withdraw the application follows feedback from the European Medicines Agency’s Committee for Medicinal Products for Human Use.

Reported GAAP EPS of -$0.08 up 50.00% YoY

Anavex faces Nasdaq compliance delays from late Form 10-Q filings, paused European Phase 3 Alzheimer’s trials, and reliance on stock-based compensation reversals from former CEO termination to achieve quarterly profitability.

Anavex advanced blarcamesine toward FDA Phase 3 Alzheimer’s discussions, progressed its Rett syndrome and Fragile X programs, and held $118.3M in cash expected to fund operations into late fiscal 2028.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

AVXL Anavex Life Sciences Corp

Fundamentals

Latest AVXL News